 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 10/28/2016 |
$0.59 |
$0.65 |
$0.56 |
$0.62 |
765.80K | | 10/31/2016 |
$0.59 |
$0.62 |
$0.55 |
$0.61 |
662.90K | | 11/01/2016 |
$0.57 |
$0.61 |
$0.56 |
$0.59 |
245.80K | | 11/02/2016 |
$0.58 |
$0.63 |
$0.58 |
$0.61 |
527.00K | | 11/03/2016 |
$0.68 |
$0.71 |
$0.52 |
$0.65 |
2.30M |
|
|
| Albireo Pharma is a biopharmaceutical company focused on the development and commercialization of treatments for diabetes. Co.'s primary product candidate is a glucagon emergency management (GEM) drug-device combination that is intended to treat diabetes patients experiencing severe hypoglycemia, or very low concentrations of blood glucose. In addition to its GEM product, Co. is developing ultra-rapid-acting proprietary insulin formulations that are designed to be more rapid-acting for Type 1 and Type 2 diabetes patients. Also, Co. has used its proprietary excipients to develop pre-clinical analog-based ultra-rapid-acting insulin formulations using either insulin lispro or insulin aspart. | |
|
BIOD (BIOD) has the following price history information. Looking back at BIOD historical stock prices for the last five trading days, on October 28, 2016, BIOD opened at $0.59, traded as high as $0.65 and as low as $0.56, and closed at $0.62. Trading volume was a total of 765.80K shares. On October 31, 2016, BIOD opened at $0.59, traded as high as $0.62 and as low as $0.55, and closed at $0.61. Trading volume was a total of 662.90K shares. On November 01, 2016, BIOD opened at $0.57, traded as high as $0.61 and as low as $0.56, and closed at $0.59. Trading volume was a total of 245.80K shares. On November 02, 2016, BIOD opened at $0.58, traded as high as $0.63 and as low as $0.58, and closed at $0.61. Trading volume was a total of 527.00K shares. On November 03, 2016, BIOD opened at $0.68, traded as high as $0.71 and as low as $0.52, and closed at $0.65. Trading volume was a total of 2.30M shares.
BIOD Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into BIOD shares, starting with a $10,000 purchase of BIOD, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
12/11/2013 |
|
| End date: |
11/03/2016 |
|
| Start price/share: |
$2.02 |
|
| End price/share: |
$0.65 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-67.82% |
|
| Average Annual Total Return: |
-32.40% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$3,217.69 |
|
| Years: |
2.90 |
|
|
|
| Date |
Close |
| 10/28/2016 | $0.62 | | 10/31/2016 | $0.61 | | 11/01/2016 | $0.59 | | 11/02/2016 | $0.61 | | 11/03/2016 | $0.65 |
|
|
Free BIOD Email Alerts:
